ION BEAM APPLICATIONS (IBAB.BR) Stock Price, Forecast & Analysis
Europe - EBR:IBAB - BE0003766806 - Common Stock
IBAB.BR Key Statistics, Chart & Performance
The current stock price of IBAB.BR is 10 EUR. In the past month the price decreased by -10.14%. In the past year, price decreased by -26.49%.
IBAB.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.24 | 111.58B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 18.38 | 49.34B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 21.77 | 46.67B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.26 | 22.55B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.41 | 22.75B | ||
| BIM.PA | BIOMERIEUX | 27.44 | 12.53B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.1 | 3.84B | ||
| DIA.MI | DIASORIN SPA | 17 | 3.30B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.64 | 1.29B | ||
| DRW8.DE | DRAEGERWERK AG | 9.6 | 1.16B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.63 | 997.90M | ||
| ELN.MI | EL.EN. SPA | 18.08 | 928.26M |
Related stock screener links
About IBAB.BR
Company Profile
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,095 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
Company Info
ION BEAM APPLICATIONS
Chemin du Cyclotron 3
Louvain-la-Neuve BRABANT-WALLON BE
Employees: 1943
Phone: 3210475811
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you describe the business of ION BEAM APPLICATIONS?
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,095 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
What is the current price of IBAB stock?
The current stock price of IBAB.BR is 10 EUR. The price decreased by -0.99% in the last trading session.
Does ION BEAM APPLICATIONS pay dividends?
ION BEAM APPLICATIONS (IBAB.BR) has a dividend yield of 1.58%. The yearly dividend amount is currently 0.17.
What is the ChartMill technical and fundamental rating of IBAB stock?
IBAB.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the GICS sector and industry of IBAB stock?
ION BEAM APPLICATIONS (IBAB.BR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of IBAB stock?
ION BEAM APPLICATIONS (IBAB.BR) has a market capitalization of 302.80M EUR. This makes IBAB.BR a Small Cap stock.
IBAB.BR Technical Analysis
IBAB.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR. There are concerns on the financial health of IBAB.BR while its profitability can be described as average.
IBAB.BR Financial Highlights
Over the last trailing twelve months IBAB.BR reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS increased by 112.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.85% | ||
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| Debt/Equity | 0.23 |
IBAB.BR Forecast & Estimates
10 analysts have analysed IBAB.BR and the average price target is 14.96 EUR. This implies a price increase of 49.6% is expected in the next year compared to the current price of 10.
For the next year, analysts expect an EPS growth of 180.98% and a revenue growth 21.21% for IBAB.BR